• Study on Upadacitinib for Pain Management in Patients with Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Comparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Finland France Germany +7
  • Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Belgium Denmark France Germany Greece Italy +4
  • Study on the Safety of Allocetra for Patients with Knee Osteoarthritis

    Not recruiting

    1 1
    Investigated Diseases:
    Denmark
  • Study Comparing Cisplatin and Radiotherapy with Durvalumab and Radiotherapy for Patients with Intermediate Risk HPV-Positive Oropharyngeal Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium Italy Spain
  • Study on Alpelisib with Fulvestrant or Letrozole for Patients with Advanced Breast Cancer and PIK3CA Mutation After Previous Treatments

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark Italy
  • Study on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer

    Not recruiting

    1 1 1 1
    Belgium Czechia France Germany Hungary Italy +2
  • Study Comparing Brimonidine and Timolol Eye Drops for Patients with Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Greece
  • Study of Chemotherapy and Nivolumab Before and After Surgery for Patients with Non-Small Cell Lung Cancer in the Upper Lung Area

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Spain

powered by